|
Mate Hidvegi (born 9 November 1955 in Budapest, Hungary) is a Hungarian biochemist and co-inventor of Avemar and Oncomar, fermented wheat germ extract based nutraceuticals. ==Life == Hidvegi was born in Budapest, Hungary, on 9 November 1955. He studied, then taught at what is now Budapest University of Technology and Economics. After finishing university, he worked in the cereal industry and was co-developer of a patented feed advisory system based on near infrared ingredient data. Hidvegi was the pioneer in the development of technologies of mass-production and therapeutic use of instantized herbal extracts in Hungary. Between 1988-1990 Hidvegi was Post-Doctoral Fellow at the Grain Research Laboratory of the Canadian Grain Commission, Winnipeg, Canada. Returning to Hungary in 1990, Hidvegi started to work for enterprises in the natural medicine industry. He worked on an anti-cholesterol pill, Esterin, which was soon patented and marketed worldwide. Also during these years, he assisted in the development various products (such as butter substitutes, weight-loss products, a line of herbal medicines, and partly, a nasal flu vaccine) for the health and food industry. In 1996 Hidvegi was co-founder of Biromedicina (joint stock company), what is now called The First Hungarian Corporation for Cancer Research and Oncology. The company’s mission was to market Hidvegi's product Avemar, a fermented wheat germ extract-based nutraceutical. Hidvegi holds a PhD and a Dr. Habil in chemistry, and an honorary professorship at the Jewish University, Budapest. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Máté Hidvégi」の詳細全文を読む スポンサード リンク
|